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Summary
The N370S mutation at the GBA locus on human chro-
mosome 1q21, which causes Gaucher disease (GD), has
a high frequency in the Ashkenazim and is the second-
most-widespread GD mutation in the European non-
Jewish population. A common ancient origin for the
N370S mutation in the Ashkenazi Jewish and Spanish
populations has been proposed on the basis of both a
similar haplotype for associated markers and an age es-
timate that suggests that this mutation appeared several
thousand years ago. However, a reappraisal of haplotype
data, using the Risch formula properly along with a
Luria-Delbru¨ck setting of the genetic clock, allows iden-
tification of the likely origin of the N370S mutation in
Ashkenazi Jews between the 11th and 13th centuries.
This result is consistent with the estimated ages of other
mutations that are frequent among Ashkenazim, with
the exception of type II (Glu117Stop) factor XI defi-
ciency, which is deemed to be 13000 years old, predating
the separation of the Ashkenazi and Iraqi Jews. The
present finding supports the hypothesis of a more recent
origin for the N370S mutation and is consistent with
both a founder chromosome transfer from Ashkenazim
who assimilated in some European populations and a
non-Jewish origin of the European N370S-bearing
chromosomes.
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Gaucher disease (GD [MIM 230800, 230900, 231000]),
first described 1100 years ago by Philippe Gaucher in a
32-year-old woman with splenomegaly (Gaucher 1882),
is the most common glycolipid storage disorder and is
caused by a deficiency in the activity of the catabolic
enzyme glucocerebrosidase (GBA: lysosomal acid b-glu-
cosidase, E.C.3.2.1.45). The defective enzyme drives N-
acyl-sphingosyl-1-O-b-D-glucoside to accumulate in
macrophages throughout the patient’s body. GD’s mode
of inheritance is autosomal recessive, and disease fre-
quency is particularly high among Ashkenazi Jews (∼1/
500 live births vs. 1/60,000–1/360,000 in the white non-
Jewish population). In Ashkenazim affected by GD, the
N370S mutation in exon 9 of the GBA gene (cDNA
1226: 5841ArG; 370AsnrSer) is by far the most com-
mon, representing 170% of GD mutations in Ashkenazi
Jewish patients (Beutler et al. 1992), with a gene fre-
quency in the population of ∼.003. Linkage disequilib-
rium (LD) has been shown between the N370S mutation
and the Pv1.1 haplotype, on the basis of the absence
of a PvuII restriction site in intron 6 of the GBA gene
(Beutler et al. 1992). N370S is also the second-most-
common GD mutation in European non-Jewish popu-
lations, with a high frequency among Portuguese and
Spanish patients (Amaral et al. 1996; Cormand et al.
1998).
Recently, Cormand et al. (1997, 1998) finely mapped
the GBA gene on chromosome 1q21 in relation to several
highly polymorphic markers and identified a putative
ancestral haplotype associated with the N370Smutation
in chromosomes from Spanish patients. Dı´az et al.
(1999) extended this study to 66 unrelated Ashkenazi
Jewish patients affected by GD and of central and east-
ern European descent, confronting their haplotypes for
1q markers, as well as those of 14 Spanish GD patients,
with the corresponding haplotypes from Ashkenazi and
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non-Jewish controls. In their otherwise interesting and
potentially useful report, the authors made some erro-
neous calculations when they attempted to estimate the
age of the N370S mutation among the Ashkenazi Jews,
using LD analysis. The source of the error lies in the use
of a wrong version of the formula (equation 1) by Risch
et al. (1995b, p. 158). The typographical error (“#”
should read “=”) was never corrected through publi-
cation of an erratum, but apparently it was known to
authors who later applied Risch et al.’s formula correctly
(e.g., Moisio et al. 1996). However, Gou and Xiong
(1997, p. 320), yielding a similar formula, had the op-
portunity to point out the misprint. Unfortunately, an-
other error plagues the same erroneous equation in Dı´az
et al.’s article (1999): the argument of the logarithm on
the numerator should be and not1Q/(1 p ) (1N
. This second slip, altering considerably theQ)/(1 p )N
value of the logarithm, prevented the authors from rec-
ognizing the original error, which would have been ev-
ident from the resulting unlikely high value of the esti-
mated age of the mutation (i.e., the square of the
expected age).
By use of data from Dı´az et al. (1999) and application
of the correct algorithm in the concise form
( )g = logd/log 1 v , (1)
where d is the LD measure originally defined by Bengts-
son and Thomson (1981) as and v is(p  p )/(1 p )D N N
the recombination fraction, the age of the N370S mu-
tation at the GBA locus can be re-estimated from
marker-allele frequencies and from the distance between
the gene under examination and five highly polymorphic
1q markers for which LD was confirmed (table 1). Based
on two assumed distances (0.025 and 0.037 cM) for
D1S2624, the only marker in LD with the GBA locus
for which v is available from both meiotic and RH map-
ping, the estimate of the age of the N370S mutation in
Ashkenazi Jews is 30–20 generations (750–500 years, if
we assume 25 years/generation) and not 381–169 gen-
erations, as reported by Dı´az et al. (1999). However, as
suggested by Labuda et al. (1996, 1997), it is likely that
the age estimated from equation (1) is an underestimate:
attention has been drawn by these authors to “the fact
that, when applied to growing populations, the genetic
clock ticks more slowly than expected” (1997, p. 769).
A straightforward approach to the problem (Labuda et
al. 1996) is to set the genetic clock, according to the
Luria-Delbru¨ck correction (Luria and Delbru¨ck 1943),
as follows:
g = g g , (2)c 0
where g is the number of generations estimated from
equation (1) and
( ) ( )g =  1/d ln vf , (3)0 d
fd being equal to in a population growing at
d de /(e  1)
a rate d (for small d values, ). In our case, markerf ≈ 1/dd
D1S2624 gives for and forg = 6.5 v = .025 g = 5.50 0
(table 1) under the assumption thatv = .037 d = .4
(Risch et al. 1995a; Labuda et al. 1997). Use of this
correction shifts the rough dating of the genomic founder
event for the N370S mutation GD in the Ashkenazi Jew-
ish population back by almost 1.5 centuries. Thus, con-
trary to Dı´az et al.’s (1999) estimate (several thousand
years BC), the founder effect could have started as late
as the first half of the second millennium AD.
Estimation of the age of the Ashkenazim’s most com-
mon GBA mutation by a genetic-clock–derived equation
is subject to two sources of errors. As noted by Dı´az et
al. (1999), the first is due to the uncertainty in the RH
and meiotic estimates of v, RH generally yielding greater
distances between marker loci than does meiotic map-
ping (Moisio et al. 1996). To reduce this effect, the au-
thors used both recombination and RH data, when
available, providing an interval for the number of gen-
erations (g) since the appearance of the mutation. Im-
proved results may be expected when gene-marker dis-
tances from finer integrated maps of chromosome 1q are
available. The second source of error is due to the fact
that LD analysis based on haplotype frequencies is sen-
sitive to sampling phenomena, and statistical fluctuation
resulting from sampling variance is difficult to calculate
(Risch et al. 1995b). Furthermore, the estimated age of
the mutation tends to vary considerably from marker to
marker. This is probably due to sampling variations in
allele frequencies and to the uncertainty intrinsic to the
age estimate. However, the exact reason for the observed
discrepancies is unknown and warrants further inves-
tigation.
Age estimates of a few mutant alleles at loci involved
in autosomal diseases of high frequency in the Ashke-
nazim, as well as of a BRCA1 mutation (185delAG)
present in this population, are obtainable from data re-
ported in the recent literature (table 2). With the notable
exception of one of the two major mutations causing
factor XI deficiency (Glu117Stop), which is common to
Ashkenazi Jews, non-Ashkenazi (Iraqi) Jews, and Arabs
and is supposed to be 12000 (Peretz et al. 1997) or 3000
(Goldstein et al. 1999) years old, the origin of investi-
gated disease-linked alleles can be dated between the
11th and 13th centuries. Use of the Luria-Delbru¨ck set-
ting of the genetic clock, as suggested by Labuda et al.
(1996, 1997), shifts the original dating of Bloom syn-
drome, familial dysautonomia, and idiopathic torsion
dystonia mutations back by 150–200 years. The cor-
rected estimated age of N370S mutation at the GBA
locus (∼635–900 years) suggests that the origin of the
founder effect occurred at the beginning of our millen-
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Table 1
Haplotype, LD Analysis, and Corrected Estimated Age of the N370S (5841ArG) Mutation in
Chromosome 1q21 of Ashkenazi Jewish Patients
MARKER ALLELE
DISTANCEa
(v)
ESTIMATED AGE
LD ANALYSISb GENERATIONSc
pd pn x
2 (P value) d g g0 gc YEARS
d
D1S305 1 .024e .586 .400 5.2 (!.5) NS ) ) ) )
.023f .586 .400 5.2 (!.5) NS ) ) ) )
D1S2140 4 .022 .956 .475 49.6 (!.001) .92 3.9 6.8 10.7 268
D1S2777 1 .011 .978 .638 33.3 (!.001) .94 5.7 8.5 14.2 355
D1S1595 5 .024 .938 .450 43.7 (!.001) .87 5.8 6.5 12.3 308
D1S2721 3 .030 .936 .338 69.1 (!.001) .90 2.9 6.0 8.9 223
D1S2624 4 .037e .578 .200 70.0 (!.001) .47 19.9 5.5 25.4 635
.025f .578 .200 70.0 (!.001) .47 29.6 6.5 36.1 903
NOTE.—NS = not significant.
a Data from Cormand et al. (1997) and Dı´az et al. (1999).
b Data from Dı´az et al. (1999).
c Estimated by equations (1), (3), and (2), respectively (see text).
d Calculated with the assumption of 25 years/generation.
e Obtained from the Stanford G3 RH panel (Research Genetics), with the assumptions of 1cR/50 kb
(Moisio et al. 1996) and 900 kb/1 cM.
f Obtained from meiotic mapping (Cormand et al. 1997).
nium, before or near the early 13th century, and is con-
sistent with the results above. Such dating precedes the
time of early migrations of Jews from Ashkenaz (me-
dieval Germany) to European countries (Barnavi 1992;
Beirnart 1992). However, as suggested by likelihood
studies (Kaplan et al. 1995), it should be noted that the
Luria-Delbru¨ck correction may be conservative (i.e.,
underestimates the true age); under this assump-g g0
tion, the founder effect would be older rather than
younger. In any case, the age estimate is consistent with
a historically plausible scenario in which a founder effect
originated in a small group of successful Jewishmigrants
that underwent a demographic expansion (Labuda et al.
1997). Robust evidence supporting the founder-effect
hypothesis to explain the high frequency of the N360S
mutation observed in Ashkenazi Jews comes from strong
LD with specific alleles at adjacent genetic loci. It has
previously been shown (Beutler et al. 1992) that the
Pv1.1 haplotype on the GBA gene itself is in complete
LD with the N360S mutation. However, since both
Pv1.1 and Pv1.1 are common polymorphisms, two
or more independent mutational events in nucleotide
1226 of the GBA genomic sequence could have occurred
on the same haplotype in different chromosomes 1q21
at different times. More recently, a trinucleotide-repeat
polymorphism (eight alleles) was reported for the liver-
type pyruvate kinase (PKRL) gene (Lenzner et al. 1994),
which is closely linked to the GBA locus (Glenn et al.
1994; Cormand et al. 1997). The new marker locus en-
abled Rockah et al. (1998) to refine GD haplotype anal-
ysis. The degree of LD (d) between the N360S mutation
and the A1 allele of the PKRL gene, which is relatively
uncommon (7%) in Ashkenazi Jewish chromosomes,
was found to be .957. This result strongly suggests that
the mutation originated in a single founder chromosome,
thus supporting the conclusion drawn by Beutler et al.
(1992). Moreover, it has been noted (Rockah et al. 1998)
that, since GBA and PKRL are very tightly linked (!.2
cM), the deviation from complete LD ( )1 d = .043
“may reflect slippage at the repetitive site in the PKRL
gene, rather than bona fide recombination between the
two loci” (p. 235).
In conclusion, the above-mentioned evidence supports
a founder effect for the N360S mutation in Ashkenazi
Jews. Nevertheless, it does not unambiguously contrib-
ute to either the hypothesis of a genetic drift associated
with the remarkable expansion of this population in Eu-
rope during the 16th–19th centuries (Goodman 1978)
or the hypothesis of a selective advantage of heterozy-
gotes over noncarriers (Gravel et al. 1995) to explain
the present mutant allele’s high frequency. As suggested
by Goldstein et al. (1999) for the type II (Glu117Stop)
mutation causing factor XI deficiency in both Iraqi and
Ashkenazi Jews, these two possibilities may ultimately
be distinguishable by a comparison of the shape of the
affected chromosomes with those of the genealogies of
supposedly selectively neutral genomic regions. The pre-
sent re-estimation of the age of the N360S mutation in
Ashkenazi Jews does not settle the question of whether
the mutation originated in the primitive Ashkenazi Jew-
ish community (9th–13th centuries), spreading later to
various European populations by occasional intermar-
riage, or whether it was an original European mutation
introduced into the Ashkenazi Jewish population in the
Table 2
Estimated Dates of Origin of Mutations Causing Diseases among Ashkenazi Jews
DISEASE MIM LOCUS MUTATION
LINKED
MARKER ALLELE
DISTANCE
(v)
LD
(d)
ESTIMATED
AGEa
YEAR OF ORIGINbg g0 gc DATA SOURCE
Bloom syndrome 210900 15q26.1 Blm(Ash) FES C3 .012 .803 18 8 26 ∼1300 Ellis et al. 1994
Factor XI deficiency 264900 4q35 Glu117Stop (type II) ) ) ) ) ) ) ) ≤586 BC–70 ADg Peretz et al. 1997
D4S171 151 .013 .161 120c ≤1000 BC Goldstein et al. 1999
153 .064 189c
Phe283Leu (type III) D4S171 145/151 .013 .627 31c ) ) ≤1180 Goldstein et al. 1999
Familial dysautonomia 223900 9q31 DYSd D9S105 8 .036e .427 23 6 29 ∼1230 Blumenfeld et al. 1993, 1999
Idiopathic torsion dystonia 128100 9q34 DYT1AJ D9S64 2/10 .023 .556 25 7 32 ∼1150 Risch et al. 1995b
Breast-ovarian cancer 113705 17q21 BRCA1 D17S1327 ) ) ) 38f ) ) ∼1000 Neuhausen et al. 1996
185delAG et al. (330–1670)
a No. of generations. Unless otherwise stated, g values were estimated by means of equation (3) or an equivalent formula (see text); g0 and gc were obtained according to Labuda et al.
1996.
b A conversion factor of 25 years/generation and an average year of birth of 1950 for all affected and carrier subjects were assumed.
c Estimate of the coalescent time of disease chromosomes (Reich and Goldstein 1999).
d Gene not cloned.
e The original v value (.030: Blumenfeld et al. 1993) has been refined by use of the more precise genetic mapping of DYS (Blumenfeld et al. 1999).
f Value obtained by means of a maximum-likelihood method for multipoint haplotype data.
g Based on historical consideration of the time that elapsed between the destruction of the First and the Second Temples in Jerusalem.
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same way. Moreover, there are no data supporting one
of the two hypotheses of Dı´az et al. (1999) on theN370S
origin, that the mutation may have been introduced by
an ancient Jewish founder several thousand years ago,
before the divergence of Ashkenazi and non-Ashkenazi
Jewish populations.
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Accession numbers and URL for data in this article are as
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Online Mendelian Inheritance in Man (OMIM), http://www
.ncbi.nlm.nih.gov/Omim (for GD [MIM 230800,
230900, and 231000])
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